AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
150 hedge funds and large institutions have $601M invested in Aerie Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 57 increasing their positions, 45 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 148 → 150 (+2)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
150
Holding in Top 10
–
Calls
$1.69M
Puts
$242K
Top Buyers
| 1 | +$9.02M | |
| 2 | +$5.29M | |
| 3 | +$4.32M | |
| 4 |
Morgan Stanley
New York
|
+$3.62M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$3.48M |
Top Sellers
| 1 | -$14.3M | |
| 2 | -$14.3M | |
| 3 | -$12.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$11M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$9.93M |